1.Jankovic, J, Brin, MF.Therapeutic uses of botulinum toxin. N Engl J Med. 1991;25(324)(17):1186–94.
2.Delgado, M, Hirtz, D, Aisen, M, et al.Practice parameter: Pharmacologic treatment of spasticity in children and adolescents with cerebral palsy (an evidence-based review): report of the quality standards subcommittee of the American Academy of Neurology and the practice committee of the Child Neurology Society. Neurology. 2010;74(4):336–43.
4.Fehlings, D, Novak, I, Berweck, S, Hoare, B, Stott, N, Russo, R.Botulinum toxin assessment, intervention and follow-up for paediatric upper limb hypertonicity: international consensus statement. Eur J Neurol. 2010;17:38–56.
5.Love, SC, Novak, I, Kentish, M, et al.Botulinum toxin assessment, intervention and after-care for lower limb spasticity in children with cerebral palsy: international consensus statement. Eur J Neurol. 2010;17(Suppl 2):9–37.
6.Heinen, F, Desloovere, K, Schroeder, AS, et al.The updated European consensus 2009 on the use of botulinum toxin for children with cerebral palsy. Eur J Paediatr Neurol. 2010;14(1): 45–66. Epub Nov 14, 2009.
7.World Health Organization. International Classification of Functioning, Disability and Health (ICF). Geneva: World Health Organization, 2001.
8.Naumann, M, Albanese, A, Heinen, F, Molenaers, G, Relja, M.Safety and efficacy of botulinum type A following long-term use. Eur J Neurol. 2006;13(Suppl 4):35–40.
9.Goldstein, FM.Safety of high-dose botulinum toxin type A therapy for the treatment of pediatric spasticity. J Child Neurol. 2006;21:289–92.
10.Pascual-Pascual, SI, Pascual-Castroviejo, I.Safety of botulinum toxin type A in children younger than 2 years. Eur J Pediatr Neurol. 2009;13:511–15.
11.Albavera-Hernandez, C, Rodriguez, JM, Idrovo, AJ.Safety of botulinum toxin A among children with spascity secondary to cerebral palsy: systematic review of randomized clinical trials. Clin Rehabil. 2009;23:394–407.
12.Naidu, K, Smith, K, Sheedy, M, Adair, B, Yu, X, Graham, K.Systemic adverse events following botulinum toxin A therapy in children with cerebral palsy. Dev Med Child Neurol. 2010;52:139–44.
13.Kolaski, K, Ajizian, SJ, Passmore, L, Pasutharnchat, N, Koman, LA, Smith, BP.Safety profile of multilevel chemical denervation procedures using phenol or botulinum toxin or both in a pediatric population. Am J Phys Med Rehabil. 2008;87(7):556–66.
14.O’Flaherty, SJ, Janakan, V, Morrow, AM, Scheinberg, AN, Waugh, M-C A.Adverse events and health status following botulinum toxin A injections in children with cerebral palsy. Dev Med Child Neurol. 2011;53:125–30.
15.Narayanan, UG.Botulinum toxin: does the black box warning justify change in practice? Dev Med Child Neurol. 2011;53:101–2.
16.Schroeder, AS, Ertl-Wagner, B, Britsch, S, et al.Muscle biopsy substantiates long-term MRI alterations one year after a single dose of botulinum toxin injected into the lateral gastrocnemius muscle of healthy volunteers. Mov Disord. 2009;24:1494–503.
17.Albusaini, A, Crosbie, J, Shepherd, R, Daean, C, Scheinberg, A.No change in muscle passive stiffness following botulinum toxin injection in children with cerebral palsy. Dev Med Child Neurol. 2011;53:543–8.
18.Schroeder, AS, Koerte, I, Berweck, S, Ertl-Wagner, Heinen F.How doctors think and treat with botulinum toxin. Letter to the editor. Dev Med Child Neurol. 2010;52:875–6.
19.Barrett, RS.What are the long-term consequences of botulinum toxin injections in spastic cerebral palsy? Dev Med Child Neurol. 2011;53:485.
20.Bedard, P, Tardif, L, Ferland, A, et al.A medication reconciliation form and its impact on the medical record in a paediatric hospital. J Eval Clin Pract. 2009;17:222–7.
21.Chin, TY, Nattrass, GR, Selber, P, Graham, HK.Accuracy of intramuscular injection of botulinum toxin A in juvenile cerebral palsy: a comparison between needle placement and placement guided by electrical stimulation. J Pediatr Orthop. 2005;25:286–91.
22.Yang, EJ, Rha, D-W, Yoo, JK, Park, ES.Accuracy of needle placement for gastrocnemius muscle in children with cerebral palsy checked against ultrasonography. Arch Phys Med Rehabil. 2009; 90:741–4.